The FEO-CSNPs were particularly effective in downregulating oncogenes like PIK3CA, HER2, KRAS, and CCND1 while simultaneously upregulating tumor suppressors such as TP53, CDH1, and PTEN. This evidence concerns the gene CCND1 and neoplasm.